# Noom's GLP-1Rx Program Combines Medication With Behavioral Support
Noom Med has launched a GLP-1Rx program that pairs weight-loss medications like semaglutide with behavioral coaching and digital tools. The program positions itself as distinct from traditional telehealth weight-loss services by emphasizing the role of behavioral change alongside pharmaceutical intervention.
GLP-1 receptor agonists work by slowing stomach emptying and signaling fullness to the brain, reducing appetite and calorie intake. These medications have shown effectiveness for weight loss in clinical trials, with patients typically losing 10-15 percent of body weight when combined with lifestyle changes. However, the drugs work best as part of a comprehensive approach that includes dietary modifications and habit formation.
Noom's model integrates the medication with its established digital platform, which uses cognitive behavioral therapy principles to help users build sustainable eating habits. The program offers personalized coaching, food tracking, and daily lessons designed to address the behavioral patterns that contribute to weight gain. This combination acknowledges that medication alone does not create lasting change.
The program requires a virtual medical consultation where providers assess eligibility and prescribe medications when appropriate. Users then receive ongoing support through the app and coaching, with periodic check-ins to monitor progress and adjust treatment as needed.
This integrated approach reflects emerging research showing that behavioral interventions amplify medication effectiveness. A study in the Journal of the American Medical Association found that lifestyle modifications combined with GLP-1 medications produced superior long-term outcomes compared to medication alone. The drugs suppress appetite, but users still need to learn new eating patterns and coping strategies to maintain weight loss after stopping treatment.
Noom's GLP-1Rx program addresses a real gap in weight-loss care. Many telehealth services deliver medication without coaching, while traditional behavioral programs lack pharmaceutical options. By combining both, the program